review

96% of health care executives are “ready and resourced” to use digital health solutions, yet two-thirds say interoperability is “a tough but manageable challenge,” reveals new MIT Technology Review Insights report

CAMBRIDGE, Mass., June 25, 2025 /PRNewswire/ -- A new survey report by MIT Technology Review Insights reveals the best practices for…

2 months ago

MSCI Announces the Results of the MSCI 2025 Global Market Accessibility Review

NEW YORK--(BUSINESS WIRE)--MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment…

3 months ago

Premier Health Announces a Strategic Review Process to Enhance Shareholder Value

MONTRÉAL, June 19, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company” or “Premier Health”), a…

3 months ago

Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million

COPENHAGEN, Denmark, June 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered into an agreement…

3 months ago

ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA

SHANGHAI, June 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration…

3 months ago

OCI Global Receives U.S. Regulatory Approval for the Sale of its Global Methanol Business to Methanex Corporation

AMSTERDAM, June 12, 2025 /PRNewswire/ -- OCI Global (Euronext: OCI), ("OCI", the "Company") today announced that the regulatory review period…

3 months ago

New Betting Sites for UK Players – BetFoxx Leads Recommendations as Most Exciting New UK Sportsbook

New York City, NY, June 07, 2025 (GLOBE NEWSWIRE) -- Welcome to our comprehensive betting review of BetFoxx, a brand…

3 months ago

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13)…

3 months ago